亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Mouse obesity model: Mito-OB™ mouse

詳細技術說明
Dr. Mishra’s mouse model;  Mito-OB ® has a specific alteration of prohibitin gene expression in white adipose tissue.  Animals become obese and insulin resistant in a manner analogous to human obesity, diabetes and metabolic syndrome.  Existing mouse obesity molecules are based on appetite dysregulation by the leptin system or un-defined characteristics of obesity-selected strains.   For this reason the results of pharmacology and other therapeutic experiments on currently-available mouse obesity models may be  misleading or even useless.
*Abstract

Mito-OB ® mouse model elucidates the regulation of adipose tissue homeostasis and its impact on metabolic regulation. This transgenic mouse model, Mito-Ob®, over-expresses prohibitin (PHB) in adipocytes. Mito-Ob® mice developed obesity due to up-regulation of mitochondrial biogenesis in adipocytes. Mito-Ob®  female mice developed more visceral fat than male mice. MitoOb® male mice had impaired glucose homeostasis, compromised brown adipose tissue structure, and high insulin and low adiponectin levels.  Mechanistically, the inventors found that PHB overexpression enhances the cross talk between the mitochondria and the nucleus as well as it facilitates mitochondrial biogenesis. The data suggest a critical role of PHB and adipocyte mitochondria in adipose tissue homeostasis and reveal sex differences in the effect of PHB-induced adipocyte mitochondrial remodeling on whole-body metabolism. Targeting adipocyte mitochondria may provide new therapeutic opportunities for the treatment of obesity, a major risk factor for type 2 diabetes.  The transgenic mice provide a heretofore unavailable animal model (with a well defined metabolic defect) of obesity, insulin resistance and metabolic syndrome. In contrast, existing mouse obesity molecules are based on appetite dysregulation by the leptin system or un-defined characteristics of obesity-selected strains.

*Inquiry
Odd Bres,Ph.D.TechnologyManagerPh:+1(204)474.9407Email: odd.bres@umanitoba.ca
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備